COMMUNIQUÉS West-GlobeNewswire

-
Counslr Launches in Texas to Increase Access to Mental Health Support for Staff and Students
12/06/2025 -
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
12/06/2025 -
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
12/06/2025 -
Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025
12/06/2025 -
I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/06/2025 -
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
12/06/2025 -
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
12/06/2025 -
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
12/06/2025 -
Major shareholder announcement
12/06/2025 -
MedRisk Welcomes Satish Narayanan as Chief Data Officer, Expanding Data and AI Capabilities
12/06/2025 -
Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR
12/06/2025 -
Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma
12/06/2025 -
Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network
12/06/2025 -
Clariane finalise le plan de renforcement de sa structure financière avec la cession son réseau d’aide à domicile Petits-fils
12/06/2025 -
Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
12/06/2025 -
Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison
12/06/2025 -
Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH
12/06/2025 -
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
12/06/2025 -
SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
12/06/2025
Pages